Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer

被引：0
|
作者：
Cao, Hop S. Tran [1 ]
Bouvet, Michael [1 ]
Kaushal, Sharmeela [1 ]
Keleman, Alex [1 ]
Romney, Eric [1 ]
Kim, Ginna [1 ]
Fruehauf, John [1 ]
Imagawa, David K. [1 ]
Hoffman, Robert M. [2 ]
Katz, Matthew H. G. [3 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] AntiCancer Inc, San Diego, CA USA
[3] Univ Calif Irvine, Irvine, CA USA
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2011年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [21] A new liposomal formulation of gemcitabine is active in an orthotopic mouse model of pancreatic cancer
    Esser, Norbert
    Graeser, Ralph
    Bornmann, Christian
    Ziroli, Vittorio
    Unger, Clemens
    Hopt, Ulrich
    Von Dobschutz, Ernst
    Schaechtele, Christoph
    Massing, Ulli
    CANCER RESEARCH, 2006, 66 (08)
  • [22] A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice (vol 2, pg 951, 2022)
    Cortez, Natalia E.
    Lanzi, Cecilia Rodriguez
    Hong, Brian, V
    Xu, Jihao
    Wang, Fangyi
    Chen, Shuai
    Ramsey, Jon J.
    Pontifex, Matthew G.
    Mueller, Michael
    Vauzour, David
    Vahmani, Payam
    Hwang, Chang-il
    Matsukuma, Karen
    Mackenzie, Gerardo G.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (12): : 1668 - 1668
  • [23] Pancreatic stellate cells stimulate pancreatic cancer growth and metastasis: Findings of a novel orthotopic model of pancreatic cancer
    Joshi, S.
    Vonlaufen, A.
    Xu, Z.
    Daniel, B.
    Qu, C. F.
    Kumar, R. K.
    Pirola, R.
    Wilson, J.
    Goldstein, D.
    Apte, M.
    PANCREAS, 2006, 33 (04) : 472 - 473
  • [24] COMBINATION THERAPY FOR COLORECTAL CANCER METASTASIS USING AN ORTHOTOPIC XENOGRAFT MODEL
    Reuter, B.
    Li, L.
    Zhang, X.
    Margolin, D.
    DISEASES OF THE COLON & RECTUM, 2015, 58 (05) : E96 - E96
  • [25] Antimetastatic Effects of Liposomal Gemcitabine and Empty Liposomes in an Orthotopic Mouse Model of Pancreatic Cancer
    Graeser, Ralph
    Bornmann, Christian
    Esser, Norbert
    Ziroli, Vittorio
    Jantscheff, Peter
    Unger, Clemens
    Hopt, Ulrich T.
    Schaechtele, Christoph
    von Dobschuetz, Ernst
    Massing, Ulrich
    PANCREAS, 2009, 38 (03) : 330 - 337
  • [26] Optimization of an Orthotopic Mouse Model of Pancreatic Cancer to Simulate Liver Metastasis and Cancer Cachexia
    Wang, David J.
    Spadafora, Victoria
    Pryce, Benjamin R.
    Oles, Alexander
    Talbert, Erin E.
    Ostrowski, Micheal C.
    Guttridge, Denis C.
    CANCER RESEARCH, 2024, 84 (17)
  • [27] Effect of BPM 31510 on survival outcomes when used in combination with gemcitabine in a preclinical model of pancreatic cancer.
    Jimenez, Joaquin J.
    Mauro, Lucia M.
    Akmaev, Viacheslav R.
    McCook, John
    Du, Min
    Luan, Shen
    Song, Paul Y.
    Sarangarajan, Rangaprasad
    Narain, Niven R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients
    Zou, Yongkang
    Li, Jianwei
    Chen, Zhiyu
    Li, Xiaowu
    Zheng, Shuguo
    Yi, Dong
    Zhong, Ai
    Chen, Jian
    CARCINOGENESIS, 2015, 36 (06) : 676 - 684
  • [29] Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis
    Almawash, Saud A.
    Mondal, Goutam
    Mahato, Ram I.
    PHARMACEUTICAL RESEARCH, 2018, 35 (01)
  • [30] Pancreatitis confers a survival benefit in an orthotopic model of pancreatic cancer.
    Denham, D
    Zervos, M
    Franz, M
    Rosemurgy, A
    Norman, J
    GASTROENTEROLOGY, 1997, 112 (04) : A1437 - A1437
12345